LobbyingGenomic Answers for Childrens Health Alliance lobbying by quarter
Genomic Answers for Childrens Health Alliance's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $70K. Its first report covers Q2 2024; the issues it reports most are Health Issues.
Genomic Answers for Childrens Health Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $70K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$240K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)9 reports
- Health & Human Services, Dept of (HHS)9 reports
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Leavitt Partners | $240K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOSH TRENT | Chief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential Personnel | Q2 2026 |
| MELISSA PFAFF | Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate | Q2 2026 |
| ROBERT CLAYTON ALSPACH | Chief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C, Clerk - E&C, and Paid Intern - E&C | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/15for Q2 | Leavitt Partners | $30K |
| 04/20for Q1 | Leavitt Partners | $20K |
| 01/09for Q4 2025 | Leavitt Partners | $20K |
| 25/10/20for Q3 2025 | Leavitt Partners | $30K |
| 25/07/18for Q2 2025 | Leavitt Partners | $30K |
| 25/04/22for Q1 2025 | Leavitt Partners | $30K |
| 25/01/15for Q4 2024 | Leavitt Partners | $40K |
| 24/11/27for Q3 2024 | Leavitt Partners | $20K |
| 24/11/27for Q2 2024 | Leavitt Partners | $20K |
| 24/10/16for Q3 2024 | Leavitt Partners | $10K |
| 24/07/29for Q2 2024 | Leavitt Partners | Under $5,000 |
| 24/07/24for Q2 2024 | Leavitt Partners | Under $5,000 |